Ixekizumab (Taltz)

Trade Name : TALTZ

Eli Lilly and Company

INJECTION, SOLUTION

Strength 80 mg/mL

IXEKIZUMAB Interleukin-17A Antagonist [EPC],Interleukin-17A Antagonists [MoA]

Delivery Process

Submit a Request

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

We’ll Get in Touch

Once we review your request, we’ll send you an estimated price for the medicine within 2-5 days.

Confirmation and Payment

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

Submit a Request

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

Product information is meant for

Wholesalers Suppliers Exporters Doctors MOH Tender Supplies Hospitals Brand CROs Comparator Supplies Generic Cooperate Sourcing Individual Patients Indian Institutional Buyers

Disclaimer

Trade Marks displayed in compliance with provisions of: Trademark Act, 1999 u/s 30 and 30 (1) of "Fair use"

GNH India is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer from India of Ixekizumab (Taltz) which is also known as TALTZ and Manufactured by Eli Lilly and Company. It is available in strength of 80 mg/mL per ml. Read more

Ixekizumab (Taltz) is supplied for Tenders/ Emergency imports/ Un - licensed, Specials, Orphan drug/ Name patient line/ RLD supplies/ Reference listed drugs/ Comparator Drug/ Bio-Similar/ Innovator samples For Clinical trials.  Click to know price.     Read less

Packaging and Delivery

Validated Cold Chain Shipment

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Inquire directly from our website and get 5% off on any medicine!

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Read more

About GNH

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Read more
  • No data
  • No data
  • TALTZ is a humanized interleukin-17A antagonist indicated for the treatment of adults with:n
  • moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. ()n
  • active psoriatic arthritis. ()n
  • active ankylosing spondylitis. ()n
  • Plaque Psoriasisn
  • Psoriatic Arthritisn
  • Ankylosing Spondylitisn
  • TALTZ is a clear and colorless to slightly yellow solution available as:n
  • Autoinjectorn
  • Prefilled Syringen
  • Autoinjectorn
  • Prefilled Syringen
  • TALTZ is contraindicated in patients with a previous serious hypersensitivity reaction, such as anaphylaxis, to ixekizumab or to any of the excipients .n
  • Serious hypersensitivity reaction to ixekizumab or to any of the excipients. ()n
  • No data
  • Infections
  • Tuberculosis (TB)
  • Hypersensitivity
  • Inflammatory Bowel Disease
  • The following adverse drug reactions are discussed in greater detail in other sections of the label:n
  • Most common (u22651%) adverse reactions associated with TALTZ treatment are injection site reactions, upper respiratory tract infections, nausea, and tinea infections. ()n
  • To report SUSPECTED ADVERSE REACTIONS, contact Eli Lilly and Company at 1-800-545-5979 (1-800-LillyRx) or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
  • Live Vaccines: Live vaccines should not be given with TALTZ. ()n
  • No data
  • In the event of overdosage, monitor the patient for any signs or symptoms of adverse reactions and institute appropriate symptomatic treatment immediately.n
  • Ixekizumab is a humanized immunoglobulin G subclass 4 (IgG4) monoclonal antibody (mAb) with neutralizing activity against IL-17A. Ixekizumab is produced by recombinant DNA technology in a recombinant mammalian cell line and purified using standard technology for bioprocessing. Ixekizumab is comprised of two identical light chain polypeptides of 219 amino acids each and two identical heavy chain polypeptides of 445 amino acids each, and has a molecular weight of 146,158 Daltons for the protein backbone of the molecule.n
  • TALTZ injection is a sterile, preservative free, clear and colorless to slightly yellow solution, for subcutaneous use available as 80u00a0mg of ixekizumab in a 1u00a0mL single-dose prefilled autoinjector or a single-dose prefilled syringe. The prefilled autoinjector and prefilled syringe each contain a 1u00a0mL glass syringe with a fixed 27 gauge u00bdu00a0inch needle. The TALTZ 80u00a0mg prefilled autoinjector and prefilled syringe are manufactured to deliver 80u00a0mg of ixekizumab.n
  • Each mL is composed of ixekizumab (80u00a0mg); Citric Acid Anhydrous, USP (0.51u00a0mg); Polysorbate 80, USP (0.3u00a0mg); Sodium Chloride, USP (11.69u00a0mg); Sodium Citrate Dihydrate, USP (5.11u00a0mg); and Water for Injection, USP. The TALTZ solution has a pH of 5.3 u2013 6.1.n
  • No data
  • Animal studies have not been conducted to evaluate the carcinogenic or mutagenic potential of TALTZ. Moreover published literature is mixed on potential effects on malignancy risk due to the inhibition of IL-17A activity, the pharmacological action of TALTZ. Some published literature suggests that IL-17A directly promotes cancer cell invasion, suggesting a potential beneficial effect by TALTZ, whereas other reports indicate IL-17A promotes T-cell mediated tumor rejection, suggesting a potential adverse effect by TALTZ. However, neutralization of IL-17A with TALTZ has not been studied in these models. Depletion of IL-17A with a neutralizing antibody inhibited tumor development in mice, suggesting a potential beneficial effect by TALTZ. The relevance of experimental findings in mouse models for malignancy risk in humans is unknown.n
  • No effects on fertility parameters such as reproductive organs, menstrual cycle length, or sperm analysis were observed in sexually mature cynomolgus monkeys that were administered ixekizumab for 13 weeks at a subcutaneous dose of 50u00a0mg/kg/week (19 times the MRHD on a mg/kg basis). The monkeys were not mated to evaluate fertility.n
  • No data
  • No data
  • Advise the patient and/or caregiver to read the FDA-approved patient labeling before the patient starts using TALTZ, and each time the prescription is renewed, as there may be new information they need to know.n
  • No data
  • No data
  • No data
  • open heren
  • 1 Single-Dose prefilled autoinjectorn
  • taltzn
  • (ixekizumab) injectionn
  • 80 mg/mLn
  • For Subcutaneous Use Onlyn
  • Single-Dose Onlyn
  • NDC 0002-1445-11n
  • Each prefilled autoinjector contains 80 mg of TALTZ.n
  • Rx Onlyn
  • Dispense enclosed Medication Guide to each patient.n
  • Lillyn
  • open heren
  • 1 Single-Dose prefilled syringen
  • taltzn
  • (ixekizumab) injectionn
  • 80 mg/mLn
  • For Subcutaneous Use Onlyn
  • Single-Dose Onlyn
  • NDC 0002-7724-11n
  • Each prefilled syringe contains 80 mg of TALTZ.n
  • Rx Onlyn
  • Dispense enclosed Medication Guide to each patient.n
  • Lillyn

Browse Our Services And Processes

Comparator Sourcing for Clinical Trials

Comparator Sourcing for Clinical Trials

GNH India brings over 10 years of experience in Comparator

Read More

Name Patient Supply

Name Patient Supply

Today, the exact cause for many rare diseases remains unknown

Read More

Validated Cold Chain Shipment

Validated Cold Chain Shipment

With shifting of pharma industry from synthetic molecules to biologic

Read More

Clinical Trials Supply

Clinical Trials Supply

STOP SOURCING..... START SMART SOURCING...... COME STRAIGHT TO THE SOURCE

Read More

Dossiers and Stability Studies

Dossiers and Stability Studies

STABILITY STUDIES STABILITY, BA / BE STUDIES Due to our active

Read More

Pharmaceutical Contract Manufacturing

Pharmaceutical Contract Manufacturing

GNH Provides Contract Manufacturing services for: Generic Medicines with following

Read More

Pricing

Pricing

PRICING POLICY Terms of sales are typically prepaid, unless otherwise

Read More

Disclaimer

Please see the Legal Notice for detailed terms and disclaimers. The Legal Notice governs the use of this Website and by accessing and using this Website you agree to be bound by and accept the Legal Notice.

Browse from other international pharmaceuticals

General

64020 Products

GNH India Brings to over 64036 Product SKUs from India all at 1 place with easy access and global deliveries.

US NDC

71247 Products

GNH India Brings to over 71252 Product SKUs from India all at 1 place with easy access and global deliveries.

Canadian DIN

51046 Products

GNH India Brings to over 51047 Product SKUs from India all at 1 place with easy access and global deliveries.

Swiss Drugs

150 Products

GNH India Brings to over 150 Product SKUs from India all at 1 place with easy access and global deliveries.

NZ Drugs

13296 Products

GNH Brings to over 13298 Product SKUs from India all at 1 place with easy access and global deliveries.

FAQ

Check out our delivery process

Can’t find what
you’re looking for?

Contact US
Pharmexcil
DB
FIEO-2016
SiteLock

Copyright © 2024 GNHIndia .com. All Rights Reserved. Please read Legal Notice for further details.

Disclaimer: Product names, logos, brands and other trademarks featured or referred to are the property of their respective trademark holders.